The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis
The DOI matches its Crossref record; 95 of the 96 references it cites were found in a registry or an index.
Abstract
Background: Antidepressants (ADs) are commonly prescribed medications, but their long-term health effects are debated. ADs disrupt multiple adaptive processes regulated by evolutionarily ancient biochemicals, potentially increasing mortality. However, many ADs also have anticlotting properties that can be efficacious in treating cardiovascular disease. We conducted a meta-analysis assessing the effects of ADs on all-cause mortality and cardiovascular events in general-population and cardiovascular-patient samples. Methods: Two reviewers independently assessed articles from PubMed, EMBASE, and Google Scholar for AD-related mortality controlling for depression and other comorbidities. From these articles, we extracted information about cardiovascular events, cardiovascular risk status, and AD class. We conducted mixed-effect meta-analyses testing sample type and AD class as moderators of all-cause mortality and new cardiovascular events. Results: Seventeen studies met our search criteria. Sample type consistently moderated health risks. In general-population samples, AD use increased the risks of mortality (HR = 1.33, 95% CI: 1.14-1.55) and new cardiovascular events (HR = 1.14, 95% CI: 1.08-1.21). In cardiovascular patients, AD use did not significantly affect risks. AD class also moderated mortality, but the serotonin reuptake inhibitors were not significantly different from tricyclic ADs (TCAs) (HR = 1.10, 95% CI: 0.93-1.31, p = 0.27). Only “other ADs” were differentiable from TCAs (HR = 1.35, 95% CI: 1.08-1.69). Mortality risk estimates increased when we analyzed the subset of studies controlling for premedication depression, suggesting the absence of confounding by indication. Conclusions: The results support the hypothesis that ADs are harmful in the general population but less harmful in cardiovascular patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The substantial correlation between various somatic symptoms speaks to a neurophysiological basis for PWS, possibly autonomic nervous system dysfunction.25,54,55”
From Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum (2020) · cites this paper as [55]
In the citing paper
“According to the recent metaanalyses, antidepressants' use was associated with a 33% increase in mortality corresponding to estimated additional 2.64 deaths per 1,000 person-years.87”
From Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review (2018) · cites this paper as [87]
In the citing paper
“Some studies have found that antidepressant use was associated with a small increase in all-cause mortality, while other meta-analysis has suggested potential differences based on population characteristics.”
From Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review (2018) · cites this paper as [87]
In the citing paper
“Similarily, the class effects of antidepressants on all cause mortality are also still elusive, although the widespread use of SSRIs is partly based on the belief that they are safer than the older TCAs.87”
From Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review (2018) · cites this paper as [87]
In the citing paper
“Antidepressants may be hazardous in the general population, but are less so in cardiovascular patients, perhaps owing to the positive effects in the clotting process involving platelet cell activation.8789”
From Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review (2018) · cites this paper as [87]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Downs, S. H., & Black, N. (1998) · Journal of Epidemiology and Community Health · doi:10.1136/jech.52.6.377 · Cited by 8,252
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,226
The New Statistics: Why and How
Cumming, G. (2014) · Psychological Science · doi:10.1177/0956797613504966 · Cited by 3,200
Residuals and Influence in Regression
Ling, R. F. (1984) · Technometrics · doi:10.1080/00401706.1984.10487996 · Cited by 2,642
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
Cited by
Davies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387
Screening and Management of Depression in Patients With Cardiovascular Disease
Jha, M. K., Qamar, A., Vaduganathan, M., Charney, D. S., & Murrough, J. W. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.041 · Cited by 365
“The use of antidepressant medications in patients with CVD has not been associated with increased mortality, especially after controlling for the presence of depressive symptoms (97,118,119).”
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299
“Early studies have suggested that newer antidepressants, SSRIs and SNRIs still have a risk of weight gain, but mirtazapine have less risk of causing weight gain than TCAs.67 It was generally accepted that paroxetine has a higher risk of weight gain amongst the SSRIs, and amitriptyline was thought to cause the most pot…”
BackgroundInfluentialPlacebo effect in the treatment of depression and anxiety
Kirsch, I. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00407 · Cited by 205
Antidepressive Mechanisms of Probiotics and Their Therapeutic Potential
Yong, S. J., Tong, T., Chew, J., & Lim, W. L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01361 · Cited by 204
O’Connor, E., Perdue, L. A., Coppola, E. L., Henninger, M. L., Thomas, R. G., & Gaynes, B. N. (2023) · JAMA · doi:10.1001/jama.2023.7787 · Cited by 128
Hengartner, M. P., & Plöderl, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00517 · Cited by 93
Benzodiazepines as a monotherapy in depressive disorders: a systematic review
Benasi, G., Guidi, J., Offidani, E., Balon, R., Rickels, K., & Fava, G. A. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000486696 · Cited by 79
Iatrogenic Factors in Psychopathology
Fava, G. A., & Rafanelli, C. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000500151 · Cited by 82
Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320980573 · Cited by 74
New Insights Into the Comorbidity of Coronary Heart Disease and Depression
Wu, Y., Zhu, B., Chen, Z., Duan, J., Luo, A., Yang, L., & Yang, C. (2019) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2019.03.002 · Cited by 77
Effects of sulforaphane in the central nervous system
Huang, C., Wu, J., Chen, D., Jin, J., Wu, Y. H., & Chen, Z. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.010 · Cited by 77
Antidepressant use and risk of adverse outcomes: population-based cohort study
Bansal, N., Hudda, M., Payne, R. A., Smith, D. J., Kessler, D., & Wiles, N. (2022) · BJPsych Open · doi:10.1192/bjo.2022.563 · Cited by 66
Siepmann, M., Weidner, K., Petrowski, K., & Siepmann, T. (2022) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-022-09572-0 · Cited by 77
Højlund, M., Andersen, K., Ernst, M. T., Correll, C. U., & Hallas, J. (2022) · World Psychiatry · doi:10.1002/wps.21010 · Cited by 68
“65-85 years, N (%) 4,554 (20) 41,477 (32) 46,031 (30) 0.”
Natural cause mortality in persons with serious mental illness
Dickerson, F., Origoni, A., Schroeder, J., Adamos, M., Katsafanas, E., Khushalani, S., Savage, C. L. G., Schweinfurth, L. A. B., Stallings, C., Sweeney, K., et al. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12880 · Cited by 56
“In the general population, however, antidepressants have been associated with a significantly increased risk of all-cause mortality in persons without, but not with, cardiovascular illness (46).”
BackgroundHe, Y., Li, H., Huang, J., Huang, S., Bai, Y., Li, Y., & Huang, W. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211030181 · Cited by 61
“Nevertheless, a growing body of evidence reveals that antidepressant use is also associated with an increased risk of adverse effects and events in older people, such as nausea, diarrhea, falls, hip fractures, cardiovascular events, all-cause mortality, and orthostatic hypotension (Coupland et al., 2011; Maslej et al.…”
BackgroundHengartner, M. P. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00275 · Cited by 52
“Continuation and maintenance therapy is not recommended due to an apparent lack of clear clinical benefits (54, 55, 96), coupled with a possibly increased vulnerability to chronic depression (58, 97), increased suicide risk (79, 83), and, in particular in older adults, higher all-cause mortality (86, 88, 98).”
BackgroundKuhlmann, S. L., Arolt, V., Haverkamp, W., Martus, P., Ströhle, A., Waltenberger, J. L., Rieckmann, N., & Müller‐Nordhorn, J. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000501502 · Cited by 58
Precision Medicine in Lifestyle Medicine: The Way of the Future?
Gray, I. D., Kross, A. R., Renfrew, M. E., & Wood, P. (2019) · American Journal of Lifestyle Medicine · doi:10.1177/1559827619834527 · Cited by 50
“Several studies have shown that being advised of an increased genetic risk does not result in any significant change in health behaviors.151,152 Nor does being diagnosed and treated for hypertension,153,154 coronary heart disease,155 type 2 diabetes,156-159 or chronic disease generally.155 A study of college athletes…”
BackgroundInfluentialBradbury, M., Hutton, B., Beltran-Bless, A.-A., Alzahrani, M. J., Lariviere, T., Fernandes, R., Ibrahim, M. F. K., Cole, K. M., Hilton, J. F., Vandermeer, L., et al. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.10.003 · Cited by 46
Exploring the Role of Serotonin as an Immune Modulatory Component in Cardiovascular Diseases
Imamdin, A., & van der Vorst, E. P. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021549 · Cited by 45
Grace, S. L., Medina-Inojosa, J. R., Thomas, R. J., Krause, H., Vickers-Douglas, K. S., Palmer, B. A., & Lopez-Jimenez, F. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000486794 · Cited by 39
The form and function of depressive rumination
Bartošková, M., Ševčíková, M., Durisko, Z., Maslej, M. M., Barbic, S. P., Preiss, M., & Andrews, P. W. (2018) · Evolution and Human Behavior · doi:10.1016/j.evolhumbehav.2018.01.005 · Cited by 48
Self-citationDavidson, S. K., Romaniuk, H., Chondros, P., Dowrick, C. F., Pirkis, J., Herrman, H., Fletcher, S. L., & Gunn, J. M. (2020) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419898761 · Cited by 37
“Mounting evidence suggests a potential link between antidepressant use and a range of adverse events including mortality, fractures, cardiovascular events and gastrointestinal and intracranial bleeding (Coupland et al., 2018; Frellick, 2018; Maslej et al., 2017; Rabenda et al., 2013; Yuet et al., 2019).”
BackgroundInfluentialTatschl, J. M., Hochfellner, S., & Schwerdtfeger, A. R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00738 · Cited by 47
Recent Developments in the Treatment of Depression
Hollon, S. D., Cohen, Z. D., Singla, D. R., & Andrews, P. W. (2019) · Behavior Therapy · doi:10.1016/j.beth.2019.01.002 · Cited by 40
Self-citationKonefal, S., Sherk, A., Maloney‐Hall, B., Young, M. M., Kent, P., & Biggar, E. (2022) · BMC Public Health · doi:10.1186/s12889-022-12678-z · Cited by 40
Cosci, F., & Chouinard, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00007-x · Cited by 41
Wang, L., Ren, B., Wu, S., Song, H., Xiong, L. H., Wang, F., & Shen, X. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2024.2369946 · Cited by 32
“However, compared to drug therapy, probiotics present significant advantages in terms of residual symptoms, side effects, and overall patient experience (Maslej et al. 2017).”
Neuropsychiatric disorders in patients with heart failure: not to be ignored
Manolis, T. A., Manolis, A. S., Melita, H., & Manolis, A. S. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10290-2 · Cited by 24
Evolutionary theory and the treatment of depression: It is all about the squids and the sea bass
Hollon, S. D., Andrews, P. W., Singla, D. R., Maslej, M. M., & Mulsant, B. H. (2021) · Behaviour Research and Therapy · doi:10.1016/j.brat.2021.103849 · Cited by 23
Self-citationWu, S., Zhou, Y., Xuan, Z., Xiong, L., Ge, X., Ye, J., Liu, Y., Yuan, L., Xu, Y., Ding, G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-92807-7 · Cited by 20
Göhler, A. C., Haas, J. W., Sperl, M. F. J., Hermann, C., & Winkler, A. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.037 · Cited by 19
Einsatzmöglichkeiten von Peerbegleitung in der psychiatrischen Versorgung
Mahlke, C., Schulz, G., Sielaff, G., Nixdorf, R., & Bock, T. A. (2019) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-018-2875-z · Cited by 31
Practical strategies to end coercive practices in mental health services
Funk, M., & Drew, N. (2019) · World Psychiatry · doi:10.1002/wps.20600 · Cited by 16
Cosci, F., Svicher, A., Romanazzo, S., Maggini, L., Cesaris, F. D., Benemei, S., & Geppetti, P. (2019) · CNS Spectrums · doi:10.1017/s1092852919001536 · Cited by 19
“Finally, antidepressants may provoke disturbing(68) or persistent side-effects (eg, persistent sexual side effects)(69) and may increase the risk of the occurrence of a medical disease (eg, breast cancer, cardiovascular event).(70,71)”
BackgroundAndrews, P. W., Maslej, M. M., Thomson, J. A., & Hollon, S. D. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101927 · Cited by 17
Self-citationBruun, S. B., Petersen, I., Kristensen, N. R., Cronin-Fenton, D. P., & Pedersen, A. B. (2018) · Clinical Epidemiology · doi:10.2147/clep.s166309 · Cited by 15
“A meta-analysis by Maslej et al found an increased mortality in antidepressant users compared to non-users in the general population independent of treatment indication.(31) The most common indications for SSRI treatment are depression and anxiety(10) and a systematic review by Eaton et al showed that depression and a…”
BackgroundAntidepressants and Risk of Sudden Cardiac Death: A Network Meta-Analysis and Systematic Review
Prasitlumkum, N., Cheungpasitporn, W., Tokavanich, N., Ding, K. R., Kewcharoen, J., Thongprayoon, C., Kaewput, W., Bathini, T. J., Vallabhajosyula, S., & Chokesuwattanaskul, R. (2021) · Medical Sciences · doi:10.3390/medsci9020026 · Cited by 24
“Moreover, despite the TCA’s notoriety from its side effects and poor tolerance, another large meta-analysis with total participants of up to 380,000 showed no differences in all-cause mortality and CV mortality among major antidepressants classes, including SNRI, SSRI and TCA [31].”
BackgroundOdermatt, J., Sarlon, J., Schaefer, N., Ulrich, S., Ridder, M., Schneider, E., Lang, U. E., Liwinski, T., & Brühl, A. B. (2025) · Neuroscience Applied · doi:10.1016/j.nsa.2025.105520 · Cited by 19
“Concerningly, studies indicate an increase in mortality risk associated with long-term antidepressant use in the general population, particularly due to elevated cardiovascular event risks (Hansen et al., 2016; Maslej et al., 2017).”
Kettunen, R., Taipale, H. T., Tolppanen, A., Tanskanen, A. J., Tiihonen, J., Hartikainen, S. A., & Koponen, M. (2018) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-2591-5 · Cited by 13
“Antidepressant use is also associated with an increased risk of adverse effects and events, such as falls, fractures, cardiovascular events, all-cause mortality, and upper gastrointestinal bleeding among older persons [8, 9].”
BackgroundGreene, C., Ward-Penny, H., Ioannou, M. F., Wild, S. H., Wu, H., Smıth, D. J., & Jackson, C. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110649 · Cited by 12
“Indeed, pooled results of only studies including people with, or at high risk of, cardiovascular disease similarly found that antidepressant use or prescribing was associated with a statistically non-significant reduced risk of cardiovascular morbidity [34].”
BackgroundResultPredictors of successful discontinuation of antipsychotics and antidepressants
Lincoln, T. M., Sommer, D., Quazzola, M., Witzgall, T., & Schlier, B. (2021) · Psychological Medicine · doi:10.1017/s0033291721005146 · Cited by 13
“Introduction Although detrimental effects of long-term use (⩾ 2 years) of antipsychotics (AP) and antidepressants (AD) have raised critical debates (Maslej et al., 2017; Murray et al., 2016), their longterm prescriptions are continuing to rise (e.g. Mars et al. 2017; Shoham, Cooper, Lewis,…”
BackgroundDíez, C., Lupón, J., de Antonio, M., Domingo, M., Martín-Subero, M., Rangil, T., Moliner, P., Zamora, E., Altimir, S., Santesmases, J., et al. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000491879 · Cited by 11
Zwas, D. R., Keren, A., Amir, O., & Gotsman, I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123967 · Cited by 11
Cognitive Behavior Therapy for Depression From an Evolutionary Perspective
Hollon, S. D., Andrews, P. W., & Thomson, J. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.667592 · Cited by 12
“Although SSRIs are presumed to be relative safe over the short run (one of the reasons they are preferred over the TCAs and MAOIs), a meta-analysis by Maslej and colleagues found a 30% increment in “all cause” mortality among patients free from cardiac illness (ADMs are mildly protective for the latter) (94).”
BackgroundSelf-citationCoe, A., Gunn, J. M., & Kaylor‐Hughes, C. (2022) · JMIR Research Protocols · doi:10.2196/42526 · Cited by 10
“Research suggests that these initial side effects persist with long-term use [13], which also increases the risk of gastrointestinal bleeding [14], cardiovascular disease [15], weight gain [16], and feelings of emotional numbness [17].”
BackgroundStoiljković, M., Nikolic, V. N., Ilic, N., Vujović, M., Popovic, D., Milovanovic, J. R., & Јаnkovic, S. (2023) · Pharmacology · doi:10.1159/000530084 · Cited by 11
Dong, J., Huang, J., Parisi, J. M., Zhou, Z. E., Li, M., Calderon, R., & Li, J. (2025) · Sleep Health · doi:10.1016/j.sleh.2024.12.004 · Cited by 9
Revisitando Whitaker: psicofármacos e cuidado em Saúde Mental na Atenção Primária à Saúde
Secco, A. C., & Tesser, C. D. (2023) · Saúde em Debate · doi:10.1590/0103-1104202313916 · Cited by 12
Fi, B., Sumin, A. N., Garganeeva, N. P., Ларева, Н. В., Петрова, М. М., Петрунько, О. В., Попонина, Т. М., Repin, A. N., & Собенников, В. С. (2024) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2024-13-3s-222-253 · Cited by 9
Coe, A., Gunn, J. M., Allnutt, Z., & Kaylor‐Hughes, C. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078179 · Cited by 6
Karlsen, H. R., Løchen, M., & Langvik, E. (2022) · Psychosomatic Medicine · doi:10.1097/psy.0000000000001144 · Cited by 7
“However, other studies have found that antidepressants are less likely to impact the risk of cardiovascular events in post-CVD patients (23).”
Currie, J., & Zwiers, E. (2021) · The Journal of Human Resources · doi:10.3368/jhr.1021-11986r1 · Cited by 15
Orayj, K. M. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s325521 · Cited by 5
Häger, K., Temps, T., & Krause, O. (2018) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-018-0451-9 · Cited by 4
Currie, J. L., & Zwiers, E. (2021) · National Bureau of Economic Research · doi:10.3386/w29439 · Cited by 6
“Long-term use of antidepressants has side effects, including significant weight gain, sexual problems, emotional numbness, a higher risk of new cardiovascular events, and even a higher risk of death (Bet et al. 2013; Maslej et al. 2017).”
Senescence and Late-Onset Hypogonadism
Rolf, C., Zitzmann, M., & Nieschlag, E. (2023) · Springer eBooks · doi:10.1007/978-3-031-31574-9_25 · Cited by 3
Generalization and enhancement of the effects of an active placebo nasal spray on sadness
Wilhelm, M., Fischer, S. M., Rief, W., Fiorio, M., & Barbiani, D. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.045 · Cited by 3
A rating scale to inform successful discontinuation of antipsychotics and antidepressants
Lincoln, T. M., Sommer, D., Könemund, M., & Schlier, B. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.113768 · Cited by 3
Association of pharmacotherapy with all-cause mortality among patients with irritable bowel syndrome
Mehravar, S., Yeo, Y. H., Pimentel, M., Naji, P., Ng, W. H., Burger, N., Takakura, W., & Rezaie, A. R. (2026) · Communications Medicine · doi:10.1038/s43856-026-01498-6 · Cited by 2
“Antidepressants may increase arrhythmia risk, particularly through QT prolongation, which is linked to sudden cardiac events 24 – 26 .”
Ihenetu, F. C., Nnaji, N. D., Anumudu, C. K., Ekwueme, C. T., Uhegwu, C. C., Aleke, J. C., Ezechukwu, P. S., Okwo, C. R., & Onyeaka, H. N. (2026) · Acta Microbiologica Hellenica · doi:10.3390/amh71030022 · Cited by 2
“Long-term antidepressant use has been associated with weight gain, metabolic disturbances, cardiovascular complications, abnormal platelet function, and increased bleeding risk [84–88].”
White, J. (2022) · Preventive Medicine · doi:10.1016/j.ypmed.2022.107058 · Cited by 3
“Associations with mortality may also arise through an increased susceptibility to illness caused directly by disadvantage in childhood (Lundberg, 1993), psychiatric medication shortening lifespan (Maslej et al., 2017; Ralph and Espinet, 2018), or a combination of these mechanisms.”
BackgroundAmundsen, E. J., Odsbu, I., Skurtveit, S. O., & Gjersing, L. (2024) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5763 · Cited by 2
“24 29 – 31 Maslej et al. 32 state that their study supports the hypothesis that antidepressants are harmful in the general population.”
ResultYang, M. A., Lantta, T., Vahlberg, T. J., Anttila, M., Normand, S. T., & Välimäki, M. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116065 · Cited by 2
Influence of Zhigancao decoction on chronic heart failure combined with depression
Wang, Y., Wang, J., Lv, W., Chen, H., Zhang, Y., Yang, Q., Ma, X., Guo, R., & Zhang, Q. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1538940 · Cited by 2
Högberg, G., & Bremberg, S. G. (2018) · European Journal of Public Health · doi:10.1093/eurpub/cky268 · Cited by 2
Lycke, K. D., Christiansen, C. F., Lund, J. N., Iversen, L. H., & Nørgaard, M. (2019) · Colorectal Disease · doi:10.1111/codi.14579 · Cited by 2
Sakamoto, R., & Koyama, A. (2021) · Cureus · doi:10.7759/cureus.12673 · Cited by 2
“However, antidepressants and antipsychotics have been reported to pose risks in patients with chronic heart failure [7,8].”
BackgroundAlmotayri, A., Alghamdi, A. A. A., Almimoni, N. M., Alghamdi, T. H., Alzahrani, M. S., Elsherbiny, K., & Al-Ghamdi, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-14773-8 · Cited by 1
The combined effect of psychodynamic psychotherapy and pharmacotherapy on healthcare cost
Yonatan‐Leus, R., Abargil, M., & Cooper‐Kazaz, R. (2022) · Psychotherapy Research · doi:10.1080/10503307.2022.2032861 · Cited by 1
“…antidepressants can be associated with various side effects and health risks, including liver damage (hepatotoxicity), weight gain, diabetes, internal bleeding, cardiovascular disease, and increased mortality (Brouwers et al., 2016; Carvalho et al., 2016;Maslej et al., 2017;Miidera et al., 2020).”
BackgroundFi, B., Veltishchev, D. Y., Volel, B. A., Garganeeva, N. P., Kopylov, F. Y., Lareva, N. V., Medvedev, V. E., Mosolov, S. N., Petrova, M. M., Петрунько, О. В., et al. (2025) · Kardiologiia · doi:10.18087/cardio.2025.6.n2921 · Cited by 3
James, A., Niraj, S., Mittal, M., & Niraj, G. (2021) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2021-0051 · Cited by 2
Are Antidepressants Harmful in the “General Population”?
Rosenblat, J. D., Smith, S. H., & McIntyre, R. S. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000487894 · Cited by 1
Donzelli, A., Schivalocchi, A., & Giudicatti, G. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4681-8 · Cited by 1
Goldstein, E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/509729 · Cited by 1
Madhavi, P., Kudagi, B. L., Buchineni, M., & Pathapati, R. M. (2018) · Advance Pharmaceutical Journal · doi:10.31024/apj.2018.3.4.3
Chandrashekar, R., Bharath Kumar, D., Manohar, V. R., & Rai, M. (2018) · Indian Journal of Pharmacy and Pharmacology · doi:10.18231/2393-9087.2018.0026
“It was observed that, depressed patients will have increased tendency of suicidal thoughts and carry increased risk of stroke and heart attack.(7) Even though TCAs has good efficacy, but they have narrow therapeutic index, and cause seizure at high dose and may cause death due to slowing of cardiac conduction causing…”
BackgroundEfficacy of antidepressants: Ten years of meta-analysis Kirša and associate
Kostic, M. V., & Mandić-Maravić, V. (2017) · Psihijatrija danas · doi:10.5937/psihdan1702091k
Generation of a New Model for RB1-deficient Pineoblastoma and Lysosome-based Therapy
Chung, E. D. (2019) · TSpace (University of Toronto)
Metabolic Acidosis in Multi Drug Poisoning with Antidepressants and Antipsychotics
Eizadi‐Mood, N., Dehghanzad, S., Sabzghabaee, A. M., & Farajzadegan, Z. (2021) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_20_106 · Cited by 1
“Elevated risks for mortality, including sudden cardiac death associated with the use of both Ap and Ad, have been evaluated previously.[5-10] Significant increases in prescribing for Ad and Ap drugs in different 1Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran,”
BackgroundTwo Perspectives of Mental Distress
Cornelius, J. T. (2021) · Psychoanalytic Inquiry · doi:10.1080/07351690.2021.1983407
“Further, a meta-analysis of 17 different studies revealed that simply taking an antidepressant increased an individual’s mortality rate by 33% (Brooks, 2017; Maslej et al., 2017).”
BackgroundMaslej, M. M., Bolker, B. M., Hollon, S. D., Mulsant, B. H., & Andrews, P. W. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000488113
Self-citationPérez, E. J. P. (2022) · Revista Española de Drogodependencias · doi:10.54108/10007 · Cited by 1
(2022) · Revista Española de Drogodependencias · doi:10.54108/10008
Greene, C., Ward-Penny, H., Ioannou, M. F., Wild, S. H., Wu, H., Smıth, D. J., & Jackson, C. (2023) · medRxiv · doi:10.1101/2023.01.27.23285097
“populations that included people with and without diabetes [9, 42].”
BackgroundSeneszenz und Altershypogonadismus
Rolf, C., Zitzmann, M., & Nieschlag, E. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-61904-9_25-1
Seneszenz und Altershypogonadismus
Rolf, C., Zitzmann, M., & Nieschlag, E. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-61901-8_25 · Cited by 1
Tura, A. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10519
Field of Study and Mental Health in Adulthood
Stenberg, A., & Tudor, S. (2024) · The Journal of Human Resources · doi:10.3368/jhr.0124-13353r2 · Cited by 2
Antidepressant Medication and Psychotherapy: Why It Matters
Chiesa, M. (2024) · British Journal of Psychotherapy · doi:10.1111/bjp.12938
Antidepressant use and all-cause mortality in depressed individuals: A real-world cohort study
Zhou, S., Wang, C., & Zhang, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327844
“For instance, a 2017 meta-analysis reported elevated mortality risk in the general population with antidepressant use (HR = 1.33, 95% CI: 1.14–1.55), yet the relationship was not observed in individuals with cardiovascular disease [23].”
InfluentialKaylor‐Hughes, C., Coe, A., Chondros, P., Densley, K., Fletcher, S. L., Chatterton, M. L., Hoyer, D., Chen, T. F., Ng, C. H., Mangin, D. A., et al. (2025) · doi:10.2196/preprints.81858
La décision d’arrêter de prendre des antidépresseurs
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00005-4
Kaylor‐Hughes, C., Coe, A., Chondros, P., Densley, K., Fletcher, S. L., Chatterton, M. L., Hoyer, D., Chen, T. F., Ng, C. H., Mangin, D. A., et al. (2026) · JMIR Research Protocols · doi:10.2196/81858
“Long-term use is often linked to a range of severe side effects, including increased risks of cardiovascular events [19], gastrointestinal bleeding [20], fractures [21], and diabetes [22].”
Metadata
- Authors
- Maslej, M. M., Bolker, B. M., Russell, M. J., Eaton, K., Durisko, Z., Hollon, S. D., Swanson, G. M., Thomson Jr., J. A., Mulsant, B. H., & Andrews, P. W.
- Affiliations
- McMaster University (CA)
- Vanderbilt University (US)
- Hamad bin Khalifa University (QA)
- Centre for Addiction and Mental Health (CA)
- ORCID
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 86
- Issue
- 5
- Pages
- 268-282
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2755406504
- Cited by
- 98
- References
- 96
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 10 · 2022: 12 · 2021: 15 · 2020: 6 · 2019: 16 · 2018: 17 · 2017: 2
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centre for Addiction and Mental Health
- Universiteit Maastricht
- University of California, San Francisco
- Luonnontieteiden ja Tekniikan Tutkimuksen Toimikunta
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- antidepressants, all-cause mortality, cardiovascular events, pre-existing cardiovascular disease, tricyclic antidepressants, serotonin reuptake inhibitors, confounding by indication, depression, cardiovascular risk, adverse drug reactions
- MeSH terms
- Antidepressive Agents, Tricyclic, Cardiovascular Diseases, Depressive Disorder, Humans, Mortality, Risk Factors, Comorbidity, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.